In conclusion this is the first meta-analysis of the diagnostic performance of cfDNA for the detection of EGFR-T790M mutation status in NSCLC patients who progressed to EGFR-TKIs and represents an attempt to provide guidance for future studies. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.